[Pulmonary fibrosis following treatment with cytostatics].
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001761:Bleomycin / Q000009:adverse effects; D002066:Busulfan / Q000009:adverse effects; D006801:Humans; D008297:Male; D008558:Melphalan / Q000009:adverse effects; D008727:Methotrexate / Q000009:adverse effects; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy; D011658:Pulmonary Fibrosis / Q000139:chemically induced*
D000970:Antineoplastic Agents; D001761:Bleomycin; D002066:Busulfan; D008558:Melphalan; D008727:Methotrexate
Lungenfibrosen nach Behandlung mit Zytostatika